Table 2.
TGF-β, FGF-β, and PDGF immunostaining intensities in the study groups
Study group | TGF-β immunostaining intensity (mean ± SD) | FGF-β immunostaining intensity (mean ± SD) | PDGF immunostaining intensity (mean ± SD) |
---|---|---|---|
Control (n=7) | 1.87±0.35 | 1.87±0.35 | 1.50±0.53 |
Sham (n=7) | 2.85±0.37a | 3.00±0.0a | 2.85±0.37a |
MMC (n=7) | 1.42±0.53b | 1.57±0.53b | 1.71±0.53b |
Infliximab (n=7) | 1.37±0.51b | 1.37±0.51b | 1.50±0.51b |
Notes:
Control group compared with sham group (P<0.01);
treatment groups compared with sham group (P<0.01).
Abbreviations: FGF-β, fibroblast growth factor beta; PDGF, platelet-derived growth factor; SD, standard deviation; TGF-β, transforming growth factor beta; MMC, mitomycin-C.